Economy

Best Hospitals for Thymus Cancer Worldwide

Published

3 years ago

27/04/2023

According to the American Association of Oncologists, thymus cancer is rare and accounts for about 0.5% of all tumors. The illness does not show any signs at the initial stage but, at the same time, has a high potential for malignancy. It is characterized by rapid growth and metastasis.

Over the years, we have accumulated statistics on the leading hospitals in Europe and the US for treating thymus cancer. And we can recommend to patients exactly where they will be treated most effectively. So keep reading, and we will share with you the necessary information.

Criteria for selecting the best hospitals for thymus cancer

Not only an error-free diagnosis and the results of further treatment but sometimes life itself depends on the correct choice of the treatment center and attending physician. Therefore, it is necessary to collect all possible information in order not to be disappointed in the chosen hospital in the future:

Hospitals specialization. It is essential in the treatment of advanced cases of thymus cancer.
It is necessary to look at clinic articles, scientific developments, and the introduction of various treatment methods for thymus cancer.
Information about oncologists and thoracic surgeons who work in this hospital.
It would be good to get acquainted with the reviews of specialists in this field but not working in this clinic.
It is advisable to choose several hospitals and compare them.
The second opinion is an opportunity to verify the accuracy of the diagnosis, to hear an alternative point of view of an experienced specialist, or to learn about alternative treatment options.

Finding a hospital with the online service AiroMedical is fast, simple, and effective. It is enough to specify the doctor’s specialty or the disease’s symptoms in the search bar to find the right specialist. Then, in a few seconds, the system will provide you with a relevant list of the hospitals.

Top hospitals for thymus cancer treatment in the United States

University Hospitals Michigan Ann Arbor

Langone Hospital New York

Wisconsin University Hospitals Madison

Benefits of Medical Treatment in the US

Several essential advantages of the list of hospitals in the US:

Reliable diagnosis, the accuracy of which determines the choice of a treatment plan and the effectiveness of the procedures.
Hybrid operating rooms, the latest microsurgical and minimally invasive operations equipment.
World-class thoracic surgeons who are proficient in all modern methods.

Top hospitals for thymus cancer treatment in Europe

University Hospital Frankfurt, Germany

Marien Hospital Marl, Germany

Teknon Medical Centre, Spain

Anadolu Medical Centre, Turkey

Benefits of medical treatment in Europe

European medicine offers the most current opportunities for timely thymus cancer detection and comprehensive diagnosis. Treatment in hospitals in Europe is also:

World leadership in the number of scientific papers and discoveries in medicine.
Use of unique developments and author’s methods.
Careful monitoring of compliance with international standards at all stages of manipulation.

Top hospitals for thymus cancer treatment in Poland

Medicover Hospital Warsaw

European Health Center Otwock

Gamma Knife Exira Center Katowice

Benefits of medical treatment in Poland

Advantages of Polish cancer treatment:

Fast and accurate examination, low-traumatic technologies.
Complex treatment, including thymus surgery, chemo, and radiotherapy.
Remote consultations with doctors after completion of therapy.

Top hospitals for thymus cancer treatment in Italy

University Hospital San Raffaele Milan

European Oncology Institute Milan

Agostino Gemelli University Policlinic Rome

Benefits of medical treatment in Italy

A whole list of hospitals in Italy has such advantages:

The best doctors with extensive experience treating thymus tumors.
Diagnostics are carried out on innovative equipment that provides 100% accuracy of results.
Healthcare costs are more affordable than in America, and the quality is not inferior.

Top hospitals for thymus cancer treatment in Germany

Helios Clinic Berlin-Buch

University Hospital Charite

University Hospital Heidelberg

Benefits of medical treatment in Germany

Several advantages of hospitals in Germany:

Hybrid operating rooms, robot-assisted surgery.
Close cooperation of German thoracic surgeons with many narrow specialists.
Pediatric thoracic surgeons and oncologists are at the disposal of young patients.

Best thymus cancer doctors worldwide

The best doctors in thymus cancer treatment:

Prof. Dr. med. Maximilian Bockhorn

Dr. med. habil. Krzysztof Wrobel

Prof. Dr. Thomas Vogl

Prof. Dr. Hans Hoffmann

Prof. Dr. Helmut Friess

Best treatment solutions for treating thymus cancer

Doctors of the best hospitals in the US and Europe treat thymus cancer using conservative methods and surgically, taking advantage of the latest oncology achievements that allow achieving success in more than 90% of cases. You can read more about each treatment method for thymus cancer on our website.

Here we will mention only a few:

Da Vinci’s robotic thymectomy. Minimally invasive surgery through four small incisions for the video camera and the robot’s “hands.” The system provides an accurate 3D image of the operating field and the accuracy of movements inaccessible to humans.
Ablation. A needle-like electrode is inserted into the patient, and an electric current is applied. It leads to a local increase in tissue temperature and the destruction of cancer cells.
Brachytherapy. It is the irradiation of the tumor with radioactive isotopes from the inside. Unique seeds with an active substance are injected directly into the cancer tissue with the help of endoscopic equipment.
Targeted therapy. Angiogenesis inhibitors (drugs that prevent the formation of blood vessels) and growth factor inhibitors are most often used.

How to get treatment in the best clinics for thymus cancer

Some diagnoses divide a person’s life into “before” and “after.” You can’t be prepared for them; they sound unfair and scary. Every day in our work, we encounter people tired of endless, fruitless trips to doctors who have almost lost hope of recovery. And how nice it is to see how people’s attitudes to life change after the first positive treatment results.

The AiroMedical project aims to help people who are faced with thymus cancer. On our platform, you will find:

Consultations of leading oncologists, information about the features of diagnosis and thymus cancer treatment.
Hospital contacts and appointments for diagnostics and treatment without queues and tedious waiting.
New therapy methods are used only in a few cancer centers.

Treating thymus cancer with AiroMedical is an opportunity to entrust your health to the best oncologist, constantly improving their professional skills. So leave us a request and get a personalized treatment program.

References

Semenchuk O. Thymus cancer treatment. AiroMedical. Updated January, 2023. https://airomedical.com/search/thymus-cancer-tymoma
Kyiashko D. Thymus cancer guide. AiroMedical. Updated March 22, 2023. https://airomedical.com/blogs/disease-guides/thymus-cancer-guide
Yuan Z., Gao S., Mu J., Xue Q., Mao Y. Long-term outcomes of 307 patients after complete thymoma resection. National library of medicine. Published May 15, 2017. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433013/

Up Next

I’m Not Threatened by Otedola’s Investment in Transcorp—Elumelu

Don't Miss

NASD Securities Market Extends Loss by 0.03%

Dipo Olowookere

Dipo Olowookere is a journalist based in Nigeria that has passion for reporting business news stories. At his leisure time, he watches football and supports 3SC of Ibadan. Mr Olowookere can be reached via [email protected]

1 Comment

Economy

Otedola Plans $100m Stake in Dangote Refinery Private Placement

Published

1 hour ago

21/05/2026

Adedapo Adesanya

By Adedapo Adesanya

Nigerian billionaire investor, Mr Femi Otedola, has announced plans to invest $100 million in the Dangote Refinery, which plans to list later this year.

Mr Otedola disclosed this on Wednesday after leading a delegation of top executives from First HoldCo on a visit to the Dangote refinery.

“On a personal note, I’ve appealed to him (Aliko Dangote). I’ve been here with him 25 times, so my compensation is he’s going to allocate to me shares worth $100 million in the private placement,” the billionaire said.

Mr Otedola had previously denied that he had any stake or funded the construction of a 650,000 barrels per day facility.

The announcement marks his next big move after increasing his stake in First Holdco as well as buying a $10 million property in London.

Mr Dangote last year said the refinery could sell up to 10 per cent stake in the listing, which is valued at about $5 billion. It is aiming for a valuation of up to $50 billion for Dangote refinery.

The billionaire is planning to make the IPO a cross-border listing to enable the refinery to draw investments from domestic and international investors.

Mr Dangote, this week, said the IPO is designed to democratise wealth creation and give Africans direct access to participate in the continent’s industrial transformation.

On his part, Mr Dangote, president of the Dangote Group, says the company is targeting a private placement of about $2 billion for the refinery.

While the actual date for the IPO is yet to be announced, Mr Otedola’s early investment indicates value and could spur other high-net-worth individuals to show interest.

Mr Otedola, an ally of Mr Dangote, led top executives of First HoldCo on a tour of the refinery and the fertiliser plants in the Lekki free trade zone area.

The team also visited key project sites such as the jetty, a facility built by Dangote industries to receive large vessels.

Economy

11 Plc, CSCS Drive NASD Market Higher by 0.32%

Published

4 hours ago

21/05/2026

Adedapo Adesanya

By Adedapo Adesanya

The NASD Over-the-Counter (OTC) Securities Exchange further chalked up 0.32 per cent on Wednesday, May 20, spurred by price appreciation in 11 Plc, and Central Securities and Clearing System (CSCS) Plc.

11 Plc, which used to be known as Mobil, added N22.11 to sell at N243.21 per unit compared with the previous day’s N221.10 per unit, and CSCS Plc gained N1.19 to trade at N71.81 per share versus Tuesday’s N70.62 per share.

The growth posted by the duo raised the market capitalisation by N8.04 billion to N2.495 trillion from N2.487 trillion, and lifted the NASD Unlisted Security Index (NSI) by 13.44 points to 4,171.19 points from 4,157.75 points.

Yesterday, there were two price losers, led by Nipco Plc, which shed N22.60 to close at N287.00 per unit compared with the preceding day’s N309.60 per unit, and FrieslandCampina Wamco, which lost 84 Kobo to sell for N150.95 per share, in contrast to the N151.79 per share it was traded a day earlier.

The volume of trades recorded at midweek dipped by 99.9 per cent to 2.3 million units from 1.9 billion units, the value of transactions fell by 93.7 per cent to N334.2 million from the preceding session’s N5.3 billion, and the number of deals went down by 43.3 per cent to 34 deals from 60 deals.

Great Nigeria Insurance (GNI) Plc remained the most active stock by value on a year-to-date basis, with 3.4 billion units worth N8.4 billion, trailed by Infrastructure Credit Guarantee (Infracredit) Plc with 2.3 billion sold for N6.5 billion, and CSCS Plc with 60.9 million units exchanged for N4.1 billion.

GNI Plc also closed the session as the most traded stock by volume on a year-to-date basis, with 3.4 billion units worth N8.4 billion, followed by Infracredit Plc with 2.3 billion units valued at N6.5 billion, and Resourcery Plc with 1.1 billion units traded for N415.7 million.

Economy

Naira Gains 53 Kobo Against Dollar at Official FX Market

Published

4 hours ago

21/05/2026

Adedapo Adesanya

By Adedapo Adesanya

The Naira broke its weakening streak in the Nigerian Autonomous Foreign Exchange Market (NAFEX) on Wednesday, May 20, after it appreciated against the US Dollar by 53 Kobo or 0.04 per cent to trade at N1,373.34/$1, in contrast to Tuesday’s closing rate of N1,373.87/$1.

The domestic currency also improved its value against the Euro in the official FX market during the midweek session by N1.99 to close at N1,592.53/€1 compared with Tuesday’s closing value of N1,594.52/€1, but depreciated against the Pound Sterling at the official FX market during the midweek session by 39 Kobo to trade at N1,840.00/£1 versus the previous day’s value of N1,839.61/£1.

Data from GTBank FX bench showed that the Naira appreciated against the Dollar yesterday by N2 to sell at N1,379/$1 versus N1,381/$1, but closed flat in the parallel market at N1,390/$1.

The performance of the local currency in the different segments of the forex market comes as the Central Bank of Nigeria (CBN) insisted that it is no longer aggressively intervening in the foreign exchange market to defend the Naira, as it held interest rate steady despite happenings in the global economy.

Governor of the apex bank, Mr Yemi Cardoso, disclosed after the Monetary Policy Committee (MPC) meeting in Abuja on Wednesday that the structure of Nigeria’s foreign exchange market has changed significantly under the ongoing reforms, adding that increased market liquidity has reduced the need for heavy intervention by the CBN.

Currency traders and investors are expected to continue monitoring CBN policy direction, foreign portfolio inflows, crude oil earnings, and external reserve performance as key indicators influencing the naira’s trajectory in the coming months.

According to Mr Cardoso, the CBN will continue with its current policy direction to sustain the fight against inflation and stabilise the exchange rate.

He described exchange rate stability as the centrepiece of the apex bank’s policy toolkit and stressed the need for stronger collaboration between monetary and fiscal authorities to reduce inflationary pressures in the economy.

As for the cryptocurrency market, it was in green on Wednesday as the US Securities and Exchange Commission (SEC) is delaying the launch of a recent wave of “novel ETFs,” including those that offer prediction-market style event contracts, to consider the implications of introducing the new products.

Prediction markets have become one of crypto’s hottest use cases over the past 18 months and now consistently record more than $15 billion in monthly trading volume across markets spanning from sports and elections to financial results and cultural events.

Dogecoin (DOGE) appreciated by 2.2 per cent to $0.1058, Solana (SOL) grew by 1.99 per cent to $86.42, Binance Coin (BNB) jumped 1.6 per cent to $652.01, TRON (TRX) rose by 1.4 per cent to $0.3604, Bitcoin (BTC) improved by 0.8 per cent to $77,769.62, Ethereum (ETH) soared by 0.5 per cent to $2,135.25, and Ripple (XRP) gained 0.5 per cent to quote at $1.37.

However, Cardano (ADA) dropped 0.4 per cent to trade at $0.2490, while the US Dollar Tether (USDT) and the US Dollar Coin (USDC) closed flat at $1.00 each.